Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2018-11-05 Major Shareholding Noti…
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
SC 13D
Major Shareholding Notification
2018-11-05 English
Regulatory Filings 2018
Regulatory Filings
2018-10-23 English
Regulatory Filings 2018
Regulatory Filings
2018-10-22 English
FORM S-1 - REGISTRATION STATEMENT
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used by companies to register securities for public offering under the Securities Act of 1933. It includes detailed information about the securities being offered, underwriting, risk factors, use of proceeds, and financial statements. This type of filing is a capital raising document and is not an annual report, earnings release, or other types of filings. The presence of terms like 'Registration Statement', 'Securities Act of 1933', 'offering price', 'underwriting', and 'prospectus' clearly indicate this is a Capital/Financing Update filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2018-10-12 English
CURRENT REPORT
Board/Management Information Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 1, 2018. It reports changes in the company's management structure, including promotions, role expansions, and termination of a senior executive. The content focuses on election of directors, appointment of officers, and compensatory arrangements, which aligns with announcements about changes in the company's board or senior management. There are no financial statements or detailed financial data present, so it is not an Annual Report, Interim Report, or Earnings Release. The document is not a proxy solicitation, voting results, or a regulatory filing of another type. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 3362 characters, which is consistent with a typical 8-K filing for management changes.
2018-10-04 English
Director's Dealing 2018
Director's Dealing
2018-09-21 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.